{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T03:10:58Z","timestamp":1726456258268},"edition-number":"0","reference-count":1,"publisher":"CRC Press","isbn-type":[{"type":"electronic","value":"9780429214943"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,3,6]]},"DOI":"10.3109\/9780203012055-26","type":"book-chapter","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T05:51:47Z","timestamp":1362462707000},"page":"375-388","source":"Crossref","is-referenced-by-count":1,"title":["Ethical considerations in multiple sclerosis clinical trials"],"prefix":"10.3109","member":"301","reference":[{"key":"ref20","unstructured":"1. Noseworthy JH, Wolinsky JS, Lublin FD, et al."}],"container-title":["Multiple Sclerosis Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.crcnetbase.com\/doi\/pdf\/10.3109\/9780203012055-26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T22:48:53Z","timestamp":1608763733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.taylorfrancis.com\/books\/9780203012055\/chapters\/10.3109\/9780203012055-26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,6]]},"ISBN":["9780429214943"],"references-count":1,"URL":"https:\/\/doi.org\/10.3109\/9780203012055-26","relation":{},"subject":[],"published":{"date-parts":[[2007,3,6]]}}}